We are live on ! Find out more
OCUL icon

Ocular Therapeutix
OCUL

79 hedge funds and large institutions have $99.6M invested in Ocular Therapeutix in 2019 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 22 increasing their positions, 21 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

555% more call options, than puts

Call options by funds: $1.22M | Put options by funds: $186K

42% more capital invested

Capital invested by funds: $70.2M → $99.6M (+$29.3M)

31% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 13

5% more funds holding

Funds holding: 75 → 79 (+4)

3.5% more ownership

Funds ownership: 48.92% → 52.42% (+3.5%)

5% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 21

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

Holders
79
Holders Change
+4
Holders Change %
+5.33%
% of All Funds
1.56%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
17
Increased
22
Reduced
21
Closed
13
Calls
$1.22M
Puts
$186K
Net Calls
+$1.03M
Net Calls Change
+$967K

Top Buyers

Rank Fund Capital Flow
1
OM
Opaleye Management
Massachusetts
+$8.11M
2
DAM
Deltec Asset Management
New York
+$398K
3
DC
Diametric Capital
Massachusetts
+$373K
4
PCM
Prelude Capital Management
New York
+$195K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$193K

Top Sellers

Rank Fund Capital Flow
1
Man Group
Man Group
United Kingdom
-$3.99M
2
BlackRock
BlackRock
New York
-$847K
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$412K
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$315K
5
N
Nuveen
North Carolina
-$203K
Name Holding Trade Value Shares
Change 		Change in
Stake
BFM
26
Boothbay Fund Management
New York
$352K -$5.04K -1,450 -2%
Neuberger Berman Group
27
Neuberger Berman Group
New York
$250K -$13.9K -4,000 -6%
California State Teachers Retirement System (CalSTRS)
28
California State Teachers Retirement System (CalSTRS)
California
$249K -$5.66K -1,628 -3%
AllianceBernstein
29
AllianceBernstein
Tennessee
$229K – – –
PCM
30
Prelude Capital Management
New York
$222K +$195K +56,164 New
Mercer Global Advisors
31
Mercer Global Advisors
Colorado
$221K -$139K -40,000 -42%
RhumbLine Advisers
32
RhumbLine Advisers
Massachusetts
$220K +$16.9K +4,864 +10%
Wells Fargo
33
Wells Fargo
California
$216K -$1.02K -293 -0.5%
UBS Group
34
UBS Group
Switzerland
$208K +$93.2K +26,812 +104%
VF
35
Virtu Financial
New York
$189K +$131K +37,735 +374%
LCS
36
Levin Capital Strategies
New York
$178K +$156K +45,000 New
Simplex Trading
37
Simplex Trading
Illinois
$171K +$80.6K +23,192 +114%
Barclays
38
Barclays
United Kingdom
$168K -$47.7K -13,732 -24%
Millennium Management
39
Millennium Management
New York
$146K +$128K +36,893 New
CM
40
Caption Management
Oklahoma
$130K -$25K -7,200 -18%
Citadel Advisors
41
Citadel Advisors
Florida
$126K +$47.2K +13,573 +74%
California Public Employees Retirement System
42
California Public Employees Retirement System
California
$117K +$103K +29,600 New
Goldman Sachs
43
Goldman Sachs
New York
$116K -$65.5K -18,845 -39%
Manulife (Manufacturers Life Insurance)
44
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$108K +$382 +110 +0.4%
AIG
45
American International Group
New York
$104K +$928 +267 +1%
NA
46
NewEdge Advisors
Louisiana
$102K +$90.3K +25,980 New
CG
47
Colony Group
Massachusetts
$95K – – –
New York State Common Retirement Fund
48
New York State Common Retirement Fund
New York
$89K – – –
VOYA Investment Management
49
VOYA Investment Management
Georgia
$89K +$18.3K +5,277 +31%
HF
50
HRT Financial
New York
$78K +$68.8K +19,800 New
1
2
3 4

OCUL Hedge Fund Activity: Q4 2019 in Review

79 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Ocular Therapeutix (OCUL) for Q4 2019, worth a combined $99.6M — up 42% from $70.2M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new OCUL positions and 13 closed out — a net gain of 4 holders — while 22 added to existing stakes and 21 trimmed.

The largest buyer was Opaleye Management, adding an estimated $8.11M. The largest seller was Man Group, cutting an estimated $3.99M.

  • 79 institutional investors held Ocular Therapeutix (OCUL) as of Q4 2019, up from 75 in Q3 2019.
  • Funds reported $99.6M of Ocular Therapeutix stock for Q4 2019, up 42% quarter-over-quarter.
  • 17 funds opened new Ocular Therapeutix positions in Q4 2019 and 13 closed out, a net change of +4 holders.
  • The largest Ocular Therapeutix buyer in Q4 2019 was Opaleye Management, an estimated $8.11M added.
  • The largest Ocular Therapeutix seller in Q4 2019 was Man Group, an estimated $3.99M sold.

Based on aggregated 13F filings for Q4 2019.